Market Insights:
Market Research Future (MRFR) has published a report stating that the global cell viability market is marked to expand at a CAGR of 9.2% during the forecast period of 2018-2023. Increasing incidences of individuals suffering from chronic diseases such as cancer and diabetes have induced high demand for technologically advanced diagnosis and treatment solutions in the healthcare sector. Rise in adoption of advanced technology in the healthcare sector and rise in prevalence of cancer and diabetes are majorly driving the growth of the global cell viability assays market. Increasing investments in research activities for the development of advanced healthcare solutions and high demand for effective treatment and diagnostic techniques are some other factors that are propelling the growth of the global cell viability assays market. However, low penetration of advanced technology and poor healthcare facilities in the underdeveloped regions are restraining the expansion of the global cell viability assays market during the forecast period.
Market Segmentation:
The global cell viability assays market has been segmented on the basis of products, cell type, applications, and end-user. Based on products, the cell viability assays market has been segmented into consumables and instruments. Among these, the consumables segment has been sub-segmented into reagents, assay kits, and microplates. The assay kits sub-segment includes tetrazolium reduction assay kits, resazurin cell viability assays kits, calcein-Am cell viability assays kits and others. Furthermore, the tetrazolium reduction assay kits are classified into MIT assay kits and others. The instruments segment has been sub-segmented into automated cell counters, flow cytometers, spectrophotometers, and cell imaging and analysis systems.
Based on cell type, the cell viability assays market has been segmented into human cells, microbial cells, and animal cells. Based on applications, the cell viability assays market has been segmented into stem cell research, clinical and diagnostic applications, drug discovery and development, and others. Based on end-user, the cell viability assays market has been segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospital and diagnostic laboratories, and others.
Browse Complete Report: https://www.marketresearchfuture.com/reports/cell-viability-assays-market-6391
No comments:
Post a Comment